Predictive Toxicology Summit

Applying in silico, in vitro and in vivo models to mitigate clinical failure.
As demonstrated by Vioxx and Exanta, failing to identify adverse effects of new drugs can be financially devestating. With budget cuts hitting the R&D field hard, ensuring candidate compounds are safe is even more important to reduce late stage attrition and product withdrawals.
But how do we cost-effectively develop and implement these in silico, in vitro and in vivo methods as early in drug discovery and development as possible? How do we demonstrate the validation of these methods?
Venue: IQPC
Start date: Mon, 24 Feb 2014 09:00:00 +0000
End date: Wed, 26 Feb 2014 17:00:00 +0000

Source: Nature Network London - Upcoming Events - November 27, 2013 Category: Science Source Type: events